These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 20298770)
1. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth. Lee JY; Kim KS; Kang YM; Kim ES; Hwang SJ; Lee HB; Min BH; Kim JH; Kim MS Int J Pharm; 2010 Jun; 392(1-2):51-6. PubMed ID: 20298770 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier. Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678 [TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500 [TBL] [Abstract][Full Text] [Related]
4. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer. Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935 [TBL] [Abstract][Full Text] [Related]
6. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
7. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874 [TBL] [Abstract][Full Text] [Related]
8. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo. Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997 [TBL] [Abstract][Full Text] [Related]
10. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090 [TBL] [Abstract][Full Text] [Related]
11. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma. Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts. Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803 [TBL] [Abstract][Full Text] [Related]
13. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
14. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418 [TBL] [Abstract][Full Text] [Related]
16. Injectable self-assembled block copolymers for sustained gene and drug co-delivery: an in vitro study. Zhang B; Jia F; Fleming MQ; Mallapragada SK Int J Pharm; 2012 May; 427(1):88-96. PubMed ID: 22016031 [TBL] [Abstract][Full Text] [Related]
17. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. Shim WS; Kim JH; Kim K; Kim YS; Park RW; Kim IS; Kwon IC; Lee DS Int J Pharm; 2007 Feb; 331(1):11-8. PubMed ID: 17049773 [TBL] [Abstract][Full Text] [Related]
18. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel. Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622 [TBL] [Abstract][Full Text] [Related]
19. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma. Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578 [TBL] [Abstract][Full Text] [Related]
20. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy. Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]